Ascent Group, LLC Eli Lilly & CO Transaction History

Ascent Group, LLC

$1.29 Billion
Q3 2024

A detailed history of Ascent Group, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Ascent Group, LLC holds 10,282 shares of LLY stock, worth $7.76 Million. This represents 0.7% of its overall portfolio holdings.

Number of Shares

10,282

Previous 10,917 5.82%

Holding current value

$7.76 Million

Previous $9.88 Million 7.84%

% of portfolio

0.7%

Previous 0.82%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$772.14 - $960.02 $490,308 - $609,612	-635 Reduced 5.82%	10,282 $9.11 Million
Q2 2024 Aug 14, 2024	SELL	$724.87 - $909.04 $289,948 - $363,616	-400 Reduced 3.53%	10,917 $9.88 Million
Q1 2024 May 15, 2024	SELL	$592.2 - $792.28 $1.23 Million - $1.65 Million	-2,080 Reduced 15.53%	11,317 $8.8 Million
Q4 2023 Feb 13, 2024	BUY	$525.19 - $619.13 $89,282 - $105,252	170 Added 1.29%	13,397 $7.81 Million
Q3 2023 Nov 14, 2023	SELL	$434.7 - $599.3 $515,988 - $711,369	-1,187 Reduced 8.24%	13,227 $7.1 Million
Q2 2023 Aug 14, 2023	SELL	$350.74 - $468.98 $516,640 - $690,807	-1,473 Reduced 9.27%	14,414 $6.76 Million
Q1 2023 May 10, 2023	BUY	$310.63 - $364.82 $108,409 - $127,322	349 Added 2.25%	15,887 $5.46 Million
Q4 2022 Feb 16, 2023	SELL	$321.55 - $374.67 $180,068 - $209,815	-560 Reduced 3.48%	15,538 $5.68 Million
Q3 2022 Nov 14, 2022	BUY	$296.48 - $337.87 $909,600 - $1.04 Million	3,068 Added 23.55%	16,098 $5.83 Million
Q2 2022 Aug 05, 2022	BUY	$278.73 - $327.27 $1.5 Million - $1.76 Million	5,375 Added 70.22%	13,030 $4.3 Million
Q1 2022 May 10, 2022	BUY	$234.69 - $291.66 $569,592 - $707,858	2,427 Added 46.42%	7,655 $2.19 Million
Q4 2021 Mar 01, 2022	BUY	$224.85 - $279.04 $1.18 Million - $1.46 Million	5,228 New	5,228 $1.27 Million

Others Institutions Holding LLY

# of Institutions

4,007

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $717B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ascent Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ascent Group, LLC with notifications on news.

Account